News | November 13, 2009

Two Key Cardiac Monitoring Companies to Expand Stress Test Capabilities

The top line shows the visible ECG, and the bottom shows the microvolt T-waves.


November 13, 2009 – Microvolt T-Wave Alternans (MTWA) technology from Cambridge Heart Inc. will be incorporated into a new module being developed for Cardiac Science’s cardiac stress test systems.

The MTWA technology integration will be distributed to cardiologists and primary care physicians and will make it more accessible. Cambridge Heart estimates 10 to 12 million higher-risk cardiac patients can benefit from an annual MTWA test, which helps detect patients with early symptoms for sudden cardiac death.

Cambridge Heart has completed the prototype development of the module, which is now subject to industry standard validation and verification processes, and regulatory approval.

For more information: www.cardiacscience.com


Additional Content

News | ECG

Oct. 27, 2026 — Monebo Technologies and Innolitics have announced that the U.S. Food and Drug Administration (FDA) has ...

Home October 29, 2026
Home
Feature | ECG | Samir Awasthi, MD, PhD

For decades, medicine has treated the electrocardiogram as a familiar, inexpensive and indispensable test, but also as ...

Home June 16, 2026
Home
News | ECG

June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...

Home June 05, 2026
Home
News | ECG

June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...

Home June 02, 2026
Home
News | ECG

May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...

Home May 08, 2026
Home
Subscribe Now